Launch the first sum of investment after the transnational medicine enterprise's medical reform

Launch the first sum of investment after the transnational medicine enterprise's medical reform
Comparable to 600 million yuan of promise Philippines on Huajian's insulinogenic production line
The transnational medicine enterprise aims at the medical reform and launches the first sum of investment
In the contest of the business opportunity of the medical reform, the transnational medicine enterprise is unwilling to be lag behind to people. Yesterday, the third largest pharmacy promise Philippines - Ann Wan of enterprise's match global specially announced, would invest 600 million yuan to set up insulinogenic production line in Beijing Econ Tech Development Zone, the new production line would go into operation in 2012. After this is issued by a medical reform scheme too, the selling for the first time of transnational medicine enterprise that has been waiting and seeing all the time.
A last to take up an official post just December one comparable to the intersection of promise and the intersection of Philippine and the intersection of Company and newly appointed the intersection of CEO and Bach Wei, fix overseas first stop of visit their on China, while at a time when the medical reform scheme has been just issued, it is self-evident that it wants to catch the wild ambition of the opportunity of dilatation of Chinese market.
"China's medical reform was still just at the starting stage, but absolutely a chance to enterprise, because the government has increased the input in fund, propose the whole people's medical insurance, this will make the medicines demand increase. " Bach Wei says, he will understand Chinese market in one week this time, hope for the biggest possible participation medical reform to the limit.
All the time, the medicine enterprises of the foreign capitals have all squeezed into hospital of China's the first, second and third with patent medicines of high price, then sit and enjoy the high profit. But the new medical reform scheme mainly slopes to the countryside, medical treatment at the basic level of community, make the basic medicine catalogue relying mainly on low priced medicine. This lets many foreign capitals giants begin to adjust one's own production route. Before this, a person in charge of transnational pharmacy enterprise says too, enterprises invested a large amount of energy in order to meet the new medical reform scheme. Comparable to the intersection of promise and Philippines, say, strengthen modelling medicining and input power of non-prescribed medicine low priced in Chinese market future too.
In addition, from the beginning of this year, has raised the tide of merging among the large-scale transnational medicine enterprises, including annexing the favor and east company of silent sand and purchasing rival Schering Plough,etc. in Pfizer. And is comparable to promise Philippines being spread and will pay attention to in succession altogether Bristol-Myers Squibb, as to this, it says the Company pays close attention to enterprises such as the non-prescribed medicine, nutriment,etc. in merging at present to comparable to promise Philippines.
News analysis
The basic medicine catalogue produces the guide of the patent medicine enterprise
The basic medicine catalogue that will be issued at the end of the month soon will not merely concern the public hospital what medicines will be chosen preferably is patient's treatment, it is a brand-new opportunity too to medicines enterprise at the same time. "This catalogue will make domestic medicines produce the market and shuffle again. " Deputy Director, traditional Chinese medicine general manager of Co., Ltd. Li ChuYuan of Hutchison China Trade Holdings of White Cloud Mountain in Guangzhou of Guangdong Province science,education,hygiene and sports committee think, no matter the pharmaceutical factory is big or small, in front of the basic medicine catalogue, nearly all face changing.
The edge medicine enterprise can be expected to return to the market
At present, include 2000 multi-type medicines in the medical catalogue that the existing medical insurance of our country can submit an expense account. And the basic medicine catalogue which our country will announce soon, through the strict screening, include 400 medicines with cheap and effective multi-type in.
Because the basic medicines all include in the basic medical insurance and submit an expense account in the catalogues, medical organization at the basic level and all allocate all sorts of policy advantages of using etc. in principle, if medicines can enter the catalogue, mean the enormous market. A lot of enterprises will look for the new way along this direction too. Some did not lack the possibility of emerging again either by the enterprises that produced cheap medicines and lived in the past.
Li ChuYuan thinks, the medical insurance medicines catalogue range in the past was too wide, the new basic medicine system narrowed the range, will make the production of enterprises more centralized.
The medicine price drops the space not already big
After our country's medical enterprise's revitalization produces strategically, it is the problem of corresponding to reality most too that the problem of the medicine price becomes beneath most mention.
"The price of domestic medicines drops the space not already big. " Li ChuYuan thinks, every province all call for bid medicines in recent years, the price has already kept a lot, and will refer to the new implementing scheme " Utilize lever of price to encourage the medicine enterprise to innovate " ,This makes many medicines enterprises very excited.
Relevant medical experts have said, the national development and reform committee was in making the price of medicines in the past, only consider that produces raw materials, artificial expenses, market,etc., has not charged the scientific and technological factor researched and developed to it, but it may take 10 years, put into 10 hundred million to develop a new medicine. If consider entering this part, then enterprise will relatively reduce for investing when developing the worry of new medicine medicine.
When to shrink to grind medicines originally and model medicine disparity?
Charge scientific and technological cost to, mean new price of medicine thereupon rising, will it be 8 day this month, in Information Office of the State Council holds the news briefing about the introduction medical reform situation, national development and reform committee Deputy Director Peng Sen has shown, will " narrow the disparity of grinding medicines and modelling medicine originally in the future " . This sounds more or less contradictory. Li ChuYuan says, generally foreign methods are all to stipulate protection period for new medicine, the price of this medicine is relatively high in the meantime, and does not allow other medicine enterprises to model. And once pass in protection period, the price will be reduced much. The relevant person guesses " Narrow the gap " Perhaps refer to grinding medicines originally of protection period.
At present, although our country has medicines that are in protecting during this period, the relevant specification is indeterminate. Li ChuYuan said, so long as the country to grinding the relevant regulation of medicine originally reasonably, even narrowed and modelled the price disparity between medicines, then the interests of medicines enterprises will not be damaged either.
|